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lncRNA Long noncoding RNA
Abbreviation Full Name
HIV-1 Human immunodeficiency virus type 1
CDK9 Cyclin denpendent kinase 9
P-TEFb Positive transcription elongation factor b
DMEM Dulbecco′s modified of Eagle′s medium
7SK snRNP 7SK small nuclear ribonucleoprotein, Hexim1/7SK/ P-TEFb
Tat Transactivator of Transcription
TPL Triptolide
HMBA Hexamethylene bisacetamide
LTR Long terminal repeats
NELF Negative elongation factor
DSIF DRB-sensitivity inducing factor
SEC Super Elongation Complex
SILAC Stable Isotopic Labeling by Amino acids in Cell culture
Pol II RNA polymerase II
E3 E3 ubiquitin ligase
HAART Highly active antiretroviral therapy
qRT-PCR Quantitaive Real Time-PCR
TAR Transactivation Response


























行筛选，发现 TPL以时间、浓度依赖性抑制 HIV-1的转录，并且 TPL可以特异
性引起 HIV-1编码蛋白 Tat的降解继而抑制 HIV-1的转录。研究显示 TPL不是通
过阻断 CycT1对于 Tat的保护作用，也不是在转录、翻译水平影响 Tat的含量，
而是通过泛素蛋白酶体降解途径促进了 Tat的降解。为了寻找在该过程中起作用
的 E3 泛素连接酶，运用亲和纯化、质谱、SILAC（稳定同位素标记氨基酸细胞
培养）蛋白组学定量技术对 Tat 相互作用蛋白进行定量分析，共鉴定出 1234 种
蛋白，其中包括 12个 E3泛素连接酶。需要指出的是，CUL4B 不是在 TPL处理


















Human immunodeficiency virus (HIV-1) is the primary retroviral agent
responsible for AIDS. One of its identified gene products, Tat protein, plays a pivotal
role in HIV-1 transcription, which functions as “on and off” switch in HIV-1 latency
and activation. Focusing on regulation of Tat is important for elucidating principle of
HIV-1 gene transcriptional elongation and developing new drug target for AIDS
therapy.
Triptolide(TPL) is a famous Chinese herbal medicine component, which can be
served as a drug in treating self-immune disease, cancer and other diseases. Its effect
on HIV-1 was reported recently, thus in this assay, we want to reveal the mechanism
behind Tat degradation promoted by TPL, which serve as a drug model to explore a
potential drug target and a new thought in HIV-1 therapy. Based on our cell model for
studying HIV-1 transcription, compared with other active ingredients extracted from
tripterygium, TPL has a better effect on inhibition in HIV-1 transcription in a time and
dose dependent manner, suggesting that the mechanism behind the inhibition is that
TPL could induce Tat degradation specifically, which is neither through blocking
CycT1 protection for Tat, nor affecting transcription or translation, but in an ubiquitin
proteasome pathway. Results show that 1234 proteins, including 12 E3 ubiquitin
ligase, by performing affinity purification, mass spectra, SILAC (stable isotopic
labeling by amino acids in cell culture). Most noteworthy is that CUL4B is involved
in Tat degradation under natural condition while not TPL treatment, and TPL doesn’t
induce Tat degradation in mono-site ubiquitination.
























































处于转录抑制状态，即潜伏。HIV-1 在 CD+4 T 细胞中的潜伏感染是治疗艾滋病
的最大障碍，近年来有科学家提出采取“shock and kill”的策略[9]用于治疗艾滋
病，该策略包括两步，首先用药物将处于静息态的 CD+4 T细胞中潜伏的 HIV-1
病毒激活，然后再联合高效抗逆转录病毒疗法（Highly active antiretroviral
therapy，HAART）疗法将激活的病毒及其感染的细胞清除，从而逐步清除体内
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